Sandoz EMA Trastuzumab Application Follows US Filing

European Filing For Herceptin Biosimilar Comes Shortly After FDA Submission

 
• By David Wallace
EMA
Sandoz has filed the trastuzumab biosimilar with the EMA

More from Biosimilars

More from Products